Back
Stoke Therapeutics Vs. Lixte Biotechnology Holdings Industry Stock Comparison
Buy
72
STOK
Stoke Therapeutics
Last Price:
15.37
Seasonality Move:
-14.01%
Sell
18
LIXT
Lixte Biotechnology Holdings
Last Price:
2.45
Seasonality Move:
10.83%
Buy
72
Stoke Therapeutics (STOK)
is a Buy
Is Stoke Therapeutics a Buy, Sell or Hold?
- The current Stoke Therapeutics [STOK] share price is $16.10. The Score for STOK is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- STOK is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
18
Lixte Biotechnology Holdings (LIXT)
is a Sell
Is Lixte Biotechnology Holdings a Buy, Sell or Hold?
- The current Lixte Biotechnology Holdings [LIXT] share price is $2.35. The Score for LIXT is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- LIXT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
STOK Stock Price Chart
What is Stoke Therapeutics's stock price today?
-
The Stoke Therapeutics share price today is $16.10
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and STOK is experiencing buying pressure, which is a positive indicator for future bullish movement.
LIXT Stock Price Chart
What is Lixte Biotechnology Holdings's stock price today?
-
The Lixte Biotechnology Holdings share price today is $2.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LIXT is experiencing selling pressure, which indicates risk of future bearish movement.
STOK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.86 | Buy |
| Relative Strength Index (14 RSI): | 74.54 | Buy |
| Chaikin Money Flow: | 969548 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.09 - 13.37) | Buy |
| Bollinger Bands (100): | (4.88 - 11.78) | Buy |
LIXT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.18 | Sell |
| Relative Strength Index (14 RSI): | 36.06 | Sell |
| Chaikin Money Flow: | -5293 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.57 - 3.29) | Sell |
| Bollinger Bands (100): | (2.09 - 3.09) | Sell |
STOK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.25 | Buy |
| 20-day SMA: | 12.33 | Buy |
| 50-day SMA: | 11.1 | Buy |
| 200-day SMA: | 6.47 | Buy |
| 8-day EMA: | 13.72 | Buy |
| 20-day EMA: | 12.7 | Buy |
| 50-day EMA: | 11.15 | Buy |
| 200-day EMA: | 8.34 | Buy |
LIXT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.51 | Sell |
| 20-day SMA: | 2.8 | Sell |
| 50-day SMA: | 2.91 | Sell |
| 200-day SMA: | 2.52 | Sell |
| 8-day EMA: | 2.51 | Sell |
| 20-day EMA: | 2.73 | Sell |
| 50-day EMA: | 2.81 | Sell |
| 200-day EMA: | 3.19 | Sell |
Stoke Therapeutics Earnings Growth & STOK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $0.35 per share.
Lixte Biotechnology Holdings Earnings Growth & LIXT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Stoke Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lixte Biotechnology Holdings Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||